F040 Vitiligo: Evidence Based Medicine Applied to Cases - Co-Morbidities

Professor Victoria Theradu discusses the comorbidities associated with vitiligo, emphasizing both autoimmune disorders and psychosocial issues that patients face. She highlights findings from extensive genome-wide association studies which indicate a shared genetic background between vitiligo and other autoimmune diseases, noting that individuals with vitiligo are at an increased risk for various autoimmune conditions. Moreover, she draws attention to the significant psychosocial effects, such as heightened levels of anxiety and depression, particularly among certain demographics like adolescents and those with visible skin lesions. Theradu references UK studies showing that a majority of newly diagnosed vitiligo patients do not receive any treatment, while a smaller percentage are prescribed antidepressants and anxiolytics to help manage their condition. She stresses the need for routine screening for thyroid disorders and psychosocial stressors during clinical assessments. Theradu also presents clinical cases that illustrate the effectiveness of home phototherapy combined with appropriate management strategies, aiming to empower patients and enhance their treatment outcomes. In conclusion, she recommends regular thyroid assessments and psychological evaluations for patients with vitiligo, along with the incorporation of home phototherapy as a safe treatment option.